Patents by Inventor FREDDY HEITZ

FREDDY HEITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds as NADPH oxidase inhibitors
    Patent number: 12202816
    Abstract: Disclosed herein are new compounds, pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: January 21, 2025
    Assignee: CALLIDITAS THERAPEUTICS SUISSE SA
    Inventors: Peter Machin, Mark Chambers, Alastair Hodges, Andrew Sharpe, Grant Wishart, Benjamin Perry, Sylvain Celanire, Freddy Heitz
  • USE OF NOX INHIBITORS FOR TREATMENT OF CANCER
    Publication number: 20240358687
    Abstract: The present invention is related to compounds, methods, compositions and uses that are able to restore responsiveness to immunotherapy, in particular immune check point inhibitors or anti-cancer vaccine or to anti-angiogenesis treatment.
    Type: Application
    Filed: May 1, 2024
    Publication date: October 31, 2024
    Inventors: Philippe WIESEL, Freddy HEITZ, Gareth THOMAS, Christopher HANLEY, Kristy FORD
  • Use of NOX inhibitors for treatment of cancer
    Patent number: 12011436
    Abstract: The present invention is related to compounds, methods, compositions and uses that are able to restore responsiveness to immunotherapy, in particular immune check point inhibitors or anti-cancer vaccine or to anti-angiogenesis treatment.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: June 18, 2024
    Assignees: CALLIDITAS THERAPEUTICS SUISSE SA, UNIVERSITY OF SOUTHAMPTON
    Inventors: Philippe Wiesel, Freddy Heitz, Gareth Thomas, Christopher Hanley, Kirsty Ford
  • NOVEL COMPOUNDS AS NADPH OXIDASE INHIBITORS
    Publication number: 20220033379
    Abstract: Disclosed herein are new compounds, pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: September 27, 2019
    Publication date: February 3, 2022
    Inventors: Peter Machin, Mark Chambers, Alastair Hodges, Andrew Sharpe, Grant Wishart, Benjamin Perry, Sylvain Celanire, Freddy Heitz
  • USE OF NOX INHIBITORS FOR TREATMENT OF CANCER
    Publication number: 20210177811
    Abstract: The present invention is related to compounds, methods, compositions and uses that are able to restore responsiveness to immunotherapy, in particular immune check point inhibitors or anti-cancer vaccine or to anti-angiogenesis treatment.
    Type: Application
    Filed: November 1, 2018
    Publication date: June 17, 2021
    Inventors: PHILIPPE WIESEL, FREDDY HEITZ, GARETH THOMAS, CHRISTOPHER HANLEY, KIRSTY FORD